Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can meal replacements help Low-Income adults beat diabetes?

NCT ID NCT05799222

First seen Jan 04, 2026 · Last updated Jun 20, 2026 · Updated 30 times

Summary

This study tests whether meal replacement products can help low-income adults with obesity and diabetes or pre-diabetes lose weight and lower blood sugar. Twenty participants will use meal replacements and be monitored for weight and A1c changes. The goal is to see if this approach is practical and effective for this population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Meal replacement products (Bariatrix)

What this could lead to

If successful, this could show that meal replacements are a practical, effective tool for weight loss and blood sugar control in low-income populations.

What could go wrong

This is a very small feasibility study with only 20 participants, so results may not apply broadly. It does not test long-term effects or compare against other treatments.

Conditions

The condition(s) this trial relates to.

Obesity Overweight prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.